Wolverine Trading’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.7K | Buy |
+24,508
| New | +$37.7K | ﹤0.01% | 1152 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2148 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1938 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1941 |
|
|
2023
Q3 | – | Sell |
-17,208
| Closed | -$37.3K | – | 1901 |
|
|
2023
Q2 | $37.3K | Buy |
+17,208
| New | +$37.3K | ﹤0.01% | 1010 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1853 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1842 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1980 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2059 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2316 |
|
|
2021
Q4 | – | Sell |
-28,168
| Closed | -$39K | – | 2430 |
|
|
2021
Q3 | $39K | Sell |
28,168
-17,138
| -38% | -$23.7K | ﹤0.01% | 1848 |
|
|
2021
Q2 | $87K | Buy |
45,306
+26,508
| +141% | +$50.9K | ﹤0.01% | 1652 |
|
|
2021
Q1 | $85K | Buy |
18,798
+7,920
| +73% | +$35.8K | ﹤0.01% | 1647 |
|
|
2020
Q4 | $38K | Buy |
+10,878
| New | +$38K | ﹤0.01% | 1404 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1821 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1849 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1851 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1871 |
|
|
2018
Q3 | – | Sell |
-1,652
| Closed | -$9K | – | 2096 |
|
|
2018
Q2 | $9K | Hold |
1,652
| – | – | ﹤0.01% | 1369 |
|
|
2018
Q1 | $9K | Buy |
+1,652
| New | +$9K | ﹤0.01% | 1369 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1977 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1773 |
|